Catheter ablation is a highly cost-effective permanent cure for supraventricular tachycardias with low early complication rates, though its exact role versus alternate therapies requires further clarification.
Answers are grounded in this paper and cite their sources.
Supports ablation consideration for SVT; leaves open optimal role versus alternatives.
The evolution of catheter ablation for the treatment of supraventricular tachycardias represents a major advance in the management of cardiac arrhythmias. Excellent results in the majority of patients undergoing the procedure, together with a low rate of early complications and a brief hospitalization, make catheter ablation a highly cost-effective permanent cure. At present, however, its place in relation to alternate therapies in the management of supraventricular tachycardias has not been clearly established owing to unresolved risk-benefit issues. Continuing technical advances will likely enable catheter ablation to be successfully applied to a broader range of cardiac arrhythmias.
No takes yet. Share an insight, caveat, or question.
Deshpande et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: